CCL2, a potent leukocyte chemoattractant, is known to induce macrophage recruitment and activation involved in diseases such as psoriasis, rheumatoid arthritis and arteriosclerosis.20–22 In addition, IL6 was upregulated, indicating that the tissues of the affected patients presented an inflammatory response in AAD. Here, CCL2 is linked to psoriasis.